Development and validation of three colorimetric charge transfer complexes for estimation of fingolimod as an antineoplastic drug in pharmaceutical and biological samples
暂无分享,去创建一个
[1] Eun-Kyung Lim,et al. Colorimetric paper sensor for visual detection of date-rape drug γ-hydroxybutyric acid (GHB) , 2021 .
[2] H. Salem,et al. Spectrofluorimetric analysis of fingolimod via complex formation with eosin Y in its pure form, pharmaceutical preparation and biological samples. , 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[3] Warakorn Limbut,et al. A portable optical colorimetric sensor for the determination of promethazine in lean cocktail and pharmaceutical doses , 2020 .
[4] A. Batista,et al. Novel approaches for colorimetric measurements in analytical chemistry - A review. , 2020, Analytica chimica acta.
[5] S. El-Adl,et al. Spectrophotometric Analysis of Azithromycin and Clarithromycin in Tablets and Human Plasma Using p-Chloranilic Acid , 2019, Analytical Chemistry Letters.
[6] T. Park,et al. Metal nanoparticles-based colorimetric methods for drug analyses , 2019, Nanoarchitectonics in Biomedicine.
[7] K. Shrivas,et al. Label-free selective detection of ampicillin drug in human urine samples using silver nanoparticles as a colorimetric sensing probe , 2017 .
[8] Anamik Shah,et al. Development and validation of Immunomodulating drug Fingolimod by RPHPLC method with detailed force degradation study , 2016 .
[9] A. Suneetha,et al. A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study. , 2016, Journal of pharmaceutical and biomedical analysis.
[10] E. B. Basalious,et al. Method Development and Validation for Fingolimod by HPLC/UV in Immediate-Release Oral Capsule and Study the Effect of Excipients on Solubility and Dissolution Behavior , 2016 .
[11] E. Pourbasheer,et al. Mixed hemimicelles solid-phase extraction based on sodium dodecyl sulfate (SDS)-coated nano-magnets for the spectrophotometric determination of Fingolomid in biological fluids. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[12] Jian-rong Wang,et al. Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720). , 2015, Journal of pharmaceutical and biomedical analysis.
[13] R. Ahmadkhaniha,et al. A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms , 2014, Scientia pharmaceutica.
[14] Somsubhra Ghosh,et al. Development of stability indicating RP-HPLC method for the estimation ofFingolimod in its bulk dosages form as per ICH guideline , 2015 .
[15] D. Banji,et al. Analytical Method Development and Validation of Fingolimod in Bulk Drug by Spectrophotometric Method as Per ICH Guidelines , 2014 .
[16] N. Ferreirós,et al. LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] O. Heudi,et al. Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandem mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.
[18] M. Zollinger,et al. Absorption and Disposition of the Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) in Healthy Volunteers: A Case of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways , 2011, Drug Metabolism and Disposition.
[19] K. Basavaiah,et al. Spectrophotometric determination of famotidine using sulphonphthalein dyes , 2011 .
[20] Volker Brinkmann,et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.
[21] P. Taylor,et al. Measurement and stability of FTY720 in human whole blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] K. Chiba. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. , 2005, Pharmacology & therapeutics.
[23] Michael D. Davis,et al. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.
[24] R. D. Jee,et al. Meeting the International Conference on Harmonisation's Guidelines on Validation of Analytical Procedures: quantification as exemplified by a near-infrared reflectance assay of paracetamol in intact tablets. , 2000, The Analyst.